Interim Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
EXPENSES
Amortization (Note 6 & 7)	$ 35,115	$ 35,115	$ 105,343	$ 105,344
Officers and Directors fees (Note 8)	12,500	4,500	42,100	127,636
Legal fees	165,111	120,899	508,143	369,786
Office & general	58,956	46,335	121,610	109,993
Patent consulting fees	1,645	446	5,954	9,465
Professional fees & services	51,200	114,289	248,900	376,689
Stock-based compensation (Note 11)	2,271,022	1,003,166	2,326,772	1,003,166
Total expenses	2,595,549	1,324,750	3,358,822	2,102,079
Gain on settlement of accrued payables (Note 8)		(318,531)		(408,531)
LOSS AND COMPREHENSIVE LOSS FOR THE PERIOD	$ (2,595,549)	$ (1,006,219)	$ (3,358,822)	$ (1,693,548)
Basic and diluted loss per common share	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted-average number of common shares outstanding, basic and diluted	2,028,288,798	1,649,490,868	1,917,599,525	1,919,092,280